Search

everythinglearnresearchcommunity

for

Search:↓

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Blood stem cells are diverse, influenced by many factors, and understanding them is key for progress in regenerative medicine.

Adipose-derived stem cells show potential for skin rejuvenation and wound healing but require more research to overcome challenges and ensure safety.

Regulating cell death in hair follicles can help prevent hair loss and promote hair growth.

Umbilical cord cells safely improve healing in long-term nonhealing wounds better than a placebo.

Skin fat plays a key role in immune defense and healing beyond just storing energy.

Fat-derived stem cells show promise for skin repair and reducing aging signs but need more research for consistent results.

The combination of oral PUVA and corticosteroids helps regrow hair in severe alopecia areata.

Skin aging is a complex process influenced by various factors, leading to wrinkles and sagging, and should be considered a disease due to its health impacts.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

lncRNA XLOC_008679 and gene KRT35 affect cashmere fineness in goats.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Nano-sized plant-based chemicals could improve cervical cancer treatment by being more effective and causing fewer side effects than current methods.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Toxic Shock Syndrome cases increased due to new factors, but decreased with public health measures and changes in tampon use.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

Two compounds from Asiasarum heterotropoides roots show potential as lung cancer treatments without harming normal cells.

Children and adults with Cushing's disease show different symptoms and males have more severe cases; surgery outcomes can be predicted by certain factors.

No cure exists for alopecia areata, and treatments are personalized.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Standardized procedures are crucial for collecting and preparing biological samples to ensure accurate clinical metabolomics results.

Extracellular vesicles show promise for treating psoriasis by reducing inflammation and skin lesions.

Non-coding RNAs could help detect and treat radiation damage.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.